Reckitt Benckiser Group plc (LON:RKT – Get Free Report) declared a dividend on Thursday, March 6th, DividendData.Co.Uk reports. Stockholders of record on Thursday, April 10th will be paid a dividend of GBX 121.70 ($1.55) per share on Thursday, May 29th. This represents a dividend yield of 2.38%. The ex-dividend date is Thursday, April 10th. This is a 51.4% increase from Reckitt Benckiser Group’s previous dividend of $80.40. The official announcement can be seen at this link.
Reckitt Benckiser Group Stock Performance
LON RKT opened at GBX 4,895 ($62.31) on Tuesday. Reckitt Benckiser Group has a 52-week low of GBX 4,034 ($51.35) and a 52-week high of GBX 5,418 ($68.97). The stock has a market cap of £33.40 billion, a PE ratio of 22.40, a P/E/G ratio of 1.10 and a beta of 0.09. The firm has a 50-day moving average of GBX 5,228.35 and a 200-day moving average of GBX 4,949.54. The company has a debt-to-equity ratio of 110.26, a quick ratio of 0.46 and a current ratio of 0.69.
Reckitt Benckiser Group (LON:RKT – Get Free Report) last issued its quarterly earnings data on Thursday, March 6th. The company reported GBX 349.70 ($4.45) earnings per share (EPS) for the quarter. Reckitt Benckiser Group had a net margin of 10.78% and a return on equity of 18.70%. On average, sell-side analysts anticipate that Reckitt Benckiser Group will post 331.2110727 EPS for the current year.
Insider Activity at Reckitt Benckiser Group
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Recommended Stories
- Five stocks we like better than Reckitt Benckiser Group
- How to Use the MarketBeat Excel Dividend Calculator
- Progress Software: Making Progress Driven by the AI Revolution
- Options Trading – Understanding Strike Price
- Intel-Taiwan Semiconductor Alliance Fuels Turnaround Hopes
- The 3 Best Blue-Chip Stocks to Buy Now
- Buffett’s Next Oil Bet: Why Occidental Is Different
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.